Skip to main content

conglomerates

Sustainability

Explainer: What the EU’s Moves to Water Down Sustainability Rules Mean for Fashion

After months of political wrangling, Europe’s Parliament has reached a deal to significantly scale back landmark corporate sustainability rules, paving the way for much laxer environmental reporting and due diligence requirements for large fashion brands.

Sustainability

Explainer: What the EU’s Moves to Water Down Sustainability Rules Mean for Fashion

After months of political wrangling, Europe’s Parliament has reached a deal to significantly scale back landmark corporate sustainability rules, paving the way for much laxer environmental reporting and due diligence requirements for large fashion brands.


Beauty

Why Beauty’s Biggest Companies Are Struggling to Grow

This season’s earnings paints a gloomy picture of the fiscal year ahead, thanks to a downturn in the US and a cooling fragrance market, but agile firms are finding brighter spots.

Beauty

Why Beauty’s Biggest Companies Are Struggling to Grow

This season’s earnings paints a gloomy picture of the fiscal year ahead, thanks to a downturn in the US and a cooling fragrance market, but agile firms are finding brighter spots.


Beauty

L’Oréal Selling €3 Billion of Bonds for Kering Beauté Deal

L’Oréal SA is selling at least €1.5 billion ($1.7 billion) of bonds in a three-part deal to help finance its acquisition of Kering Beauté.

Beauty

L’Oréal Selling €3 Billion of Bonds for Kering Beauté Deal

L’Oréal SA is selling at least €1.5 billion ($1.7 billion) of bonds in a three-part deal to help finance its acquisition of Kering Beauté.


Beauty

WeightWatchers Plans to Sell Novo Nordisk’s Wegovy Pill

The company’CEO said on Wednesday it plans to sell Novo Nordisk’s much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker.

Beauty

WeightWatchers Plans to Sell Novo Nordisk’s Wegovy Pill

The company’CEO said on Wednesday it plans to sell Novo Nordisk’s much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker.


Beauty

Exclusive: Hourglass Founder Carisa Janes Launches New Beauty Brand

Eight years after selling her prestige cosmetics line to Unilever Prestige, Janes has another brand on her hands, launching with 25 foundation shades and a face oil. Can lightning strike twice?

Beauty

Exclusive: Hourglass Founder Carisa Janes Launches New Beauty Brand

Eight years after selling her prestige cosmetics line to Unilever Prestige, Janes has another brand on her hands, launching with 25 foundation shades and a face oil. Can lightning strike twice?


Luxury

LVMH’s Watch Unit Takes Minority Stake in La Joux-Perret

The move deepens LVMH’s partnership with the high-end Swiss watch movement and component manufacturer.

Luxury

LVMH’s Watch Unit Takes Minority Stake in La Joux-Perret

The move deepens LVMH’s partnership with the high-end Swiss watch movement and component manufacturer.


Beauty

Shiseido Cuts Forecast, Announces New 2030 Strategy and Leadership

The Japanese conglomerate’s sales dipped to a nine month low in its latest earnings, which accompanied sweeping changes to leadership and the unveiling of its newest action plan.

Beauty

Shiseido Cuts Forecast, Announces New 2030 Strategy and Leadership

The Japanese conglomerate’s sales dipped to a nine month low in its latest earnings, which accompanied sweeping changes to leadership and the unveiling of its newest action plan.


Beauty

Novo Nordisk Bows Out of Metsera Takeover Battle

The Ozempic maker’s shares rose after Novo withdrew from a $10 billion takeover battle with Pfizer over obesity drug developer Metsera.

Beauty

Novo Nordisk Bows Out of Metsera Takeover Battle

The Ozempic maker’s shares rose after Novo withdrew from a $10 billion takeover battle with Pfizer over obesity drug developer Metsera.


Luxury

Is China’s Luxury Market Ready to Rebound?

The short answer is yes — but it won’t soon return to its pre-pandemic growth rates. After two years of turbulence, the market remains shaky, and brands will need to earn every sale.

Luxury

Is China’s Luxury Market Ready to Rebound?

The short answer is yes — but it won’t soon return to its pre-pandemic growth rates. After two years of turbulence, the market remains shaky, and brands will need to earn every sale.


Beauty

Kao Sales Lift 3.5% Against Cosmetics Business Reset

The Japanese conglomerate and Bioré owner’s latest earnings show early gains from its new strategy to drive beauty growth.

Beauty

Kao Sales Lift 3.5% Against Cosmetics Business Reset

The Japanese conglomerate and Bioré owner’s latest earnings show early gains from its new strategy to drive beauty growth.


Beauty

Pfizer Loses Legal Bid to Block Novo’s Metsera Offer

A judge denied Pfizer’s request to temporarily block Novo Nordisk’s $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal don’t warrant a delay.

Beauty

Pfizer Loses Legal Bid to Block Novo’s Metsera Offer

A judge denied Pfizer’s request to temporarily block Novo Nordisk’s $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal don’t warrant a delay.


Beauty

Coty Stares Into a Gucci-less Void

L’Oréal is set to take over the coveted Gucci license in a few short years, but losing a key brand is just one of the US conglomerate’s woes.

Beauty

Coty Stares Into a Gucci-less Void

L’Oréal is set to take over the coveted Gucci license in a few short years, but losing a key brand is just one of the US conglomerate’s woes.